Healthcare provider profile · identity verified

Mark E Stevens, M.D.

Family Practice · AMARILLO, TX · NPI 1891732897

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	334	105
Alprazolam	Alprazolam	209	47
Rosuvastatin Calcium	Rosuvastatin Calcium	194	71
Atorvastatin Calcium	Atorvastatin Calcium	188	61
Gabapentin	Gabapentin	184	43
Amlodipine Besylate	Amlodipine Besylate	175	60
Duloxetine Hcl	Duloxetine Hcl	159	44
Pravastatin Sodium	Pravastatin Sodium	156	57
Losartan Potassium	Losartan Potassium	148	54
Allopurinol	Allopurinol	142	41
Pantoprazole Sodium	Pantoprazole Sodium	139	41
Montelukast Sodium	Montelukast Sodium	131	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	128	47
Metformin Hcl	Metformin Hcl	124	50
Meloxicam	Meloxicam	119	37
Alendronate Sodium	Alendronate Sodium	114	31
Tamsulosin Hcl	Tamsulosin Hcl	114	34
Potassium Chloride	Potassium Chloride	108	35
Metoprolol Succinate	Metoprolol Succinate	105	35
Omeprazole	Omeprazole	99	26
Trazodone Hcl	Trazodone Hcl	99	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	92	31
Eliquis	Apixaban	89	15
Metformin Hcl Er	Metformin Hcl	88	26
Tramadol Hcl	Tramadol Hcl	87	31
Glimepiride	Glimepiride	84	27
Jardiance	Empagliflozin	82	27
Lisinopril	Lisinopril	82	30
Clonazepam	Clonazepam	81	15
Ezetimibe	Ezetimibe	81	20
Simvastatin	Simvastatin	78	25
Carvedilol	Carvedilol	77	23
Celecoxib	Celecoxib	77	20
Furosemide	Furosemide	74	26
Hydrochlorothiazide	Hydrochlorothiazide	74	31
Citalopram Hbr	Citalopram Hydrobromide	69	22
Tizanidine Hcl	Tizanidine Hcl	63	26
Albuterol Sulfate Hfa	Albuterol Sulfate	60	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	22
Metoprolol Tartrate	Metoprolol Tartrate	55	17
Oxybutynin Chloride Er	Oxybutynin Chloride	55	13
Ozempic	Semaglutide	52	12
Diazepam	Diazepam	51	20
Azithromycin	Azithromycin	48	44
Methocarbamol	Methocarbamol	47	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	45	18
Zolpidem Tartrate	Zolpidem Tartrate	45	13
Sertraline Hcl	Sertraline Hcl	42	13
Warfarin Sodium	Warfarin Sodium	41	suppressed
Farxiga	Dapagliflozin Propanediol	40	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	14
Prednisone	Prednisone	39	27
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	11
Spironolactone	Spironolactone	31	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Icosapent Ethyl	Icosapent Ethyl	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Dexlansoprazole Dr	Dexlansoprazole	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	13
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Atenolol	Atenolol	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	12
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Famotidine	Famotidine	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Finasteride	Finasteride	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Baclofen	Baclofen	13	suppressed
Estradiol	Estradiol	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Valsartan	Valsartan	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Edarbyclor	Azilsartan Med/Chlorthalidone	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Nystatin	Nystatin	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error